Acorah Software Products - Accounts Production 16.3.350 false true false true No description of principal activity 1 November 2023 30 November 2024 30 November 2024 15251402 Miss TANJENA ULLAH iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15251402 2023-10-31 15251402 2024-11-30 15251402 2023-11-01 2024-11-30 15251402 frs-core:CurrentFinancialInstruments 2024-11-30 15251402 frs-core:Non-currentFinancialInstruments 2024-11-30 15251402 frs-bus:PrivateLimitedCompanyLtd 2023-11-01 2024-11-30 15251402 frs-bus:FilletedAccounts 2023-11-01 2024-11-30 15251402 frs-bus:Micro-entities 2023-11-01 2024-11-30 15251402 frs-bus:AuditExempt-NoAccountantsReport 2023-11-01 2024-11-30 15251402 frs-bus:Director1 2023-11-01 2024-11-30
Registered number: 15251402
T U PHARMA LIMITED
Unaudited Financial Statements
For the Period 1 November 2023 to 30 November 2024
Balance Sheet
Registered number: 15251402
30 November 2024
£
Current assets 28,532
Creditors: Amounts Falling Due Within One Year (5,797 )
NET CURRENT ASSETS 22,735
TOTAL ASSETS LESS CURRENT LIABILITIES 22,735
Creditors: Amounts Falling Due After More Than One Year (69 )
NET ASSETS 22,666
CAPITAL AND RESERVES 22,666

Notes

1. General Information
T U PHARMA LIMITED is a private company, limited by shares, incorporated in England & Wales, registered number 15251402 . The registered office is 486 WALSALL ROAD, PERRY BARR, BIRMINGHAM, B42 2LU.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Miss TANJENA ULLAH
Director
26/06/2025